Page 136 - Read Online
P. 136

Hershman. J Cancer Metastasis Treat 2022;8:3  https://dx.doi.org/10.20517/2394-4722.2021.156  Page 3 of 3

               4.       Nagayama Y. Autophagy and thyroid cancer. J Cancer Metastasis Treat 2021;7:6.  DOI
               5.       Lee WK, Cheng SY. Targeting transcriptional regulators for treatment of anaplastic thyroid cancer. J Cancer Metastasis Treat
                   2021;7:27.  DOI
                                           18
               6.       Quartuccio N, Rubello D. Role of  F-FDG PET/CT in detection of hematogenous metastases of advanced differentiated thyroid
                   carcinoma: a systematic review and meta-analysis. J Cancer Metastasis Treat 2021;7:14.  DOI
               7.       Corn S, Mitmaker E, Tabar R, Ciarallo A, How J. Incidental thyroid uptake on PET scanning: epidemiology, clinical significance, and
                   management challenge. J Cancer Metastasis Treat 2021;7:41.  DOI
               8.       Matrone A, Gambale C, Prete A, et al. Systemic treatment of advanced, metastatic, medullary thyroid carcinoma. J Cancer Metastasis
                   Treat 2021;7:23.  DOI
               9.       Izkhakov E, Keinan-boker L, Stern N. Cardiovascular morbidity and mortality as a confounder of prognosis in thyroid cancer. J
                   Cancer Metastasis Treat 2021;7:24.  DOI
               10.      Priya S, Garg S, Dandekar M. Intraoperative monitoring of the recurrent laryngeal nerve in surgeries for thyroid cancer: a review. J
                   Cancer Metastasis Treat 2021;7:70.  DOI
   131   132   133   134   135   136   137   138   139   140   141